Development and Evaluation of Niosomal Gel for Transdermal Application of Steroidal API
August 2020
in “
International Research Journal on Advanced Science Hub
”
Studysummary In this study, researchers developed a niosomal gel system for transdermal delivery of testosterone, reporting strong penetrative capability, good spreadability, and a promising in vitro drug release profile, suggesting it may be an effective alternative for reducing the side effects of steroid treatments.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study developed a niosomal gel formulation for transdermal delivery of testosterone, aiming to improve drug delivery and minimize side effects associated with conventional steroid treatments. The gel was created using a mixture of non-ionic surfactant and cholesterol, with xanthan gum as the gelling agent. The niosomal gel demonstrated favorable characteristics, including small vesicle size (10-500 nm), high entrapment efficiency (92.17%), and good consistency, homogeneity, and spreadability. Various tests confirmed the gel's quality, and in vitro drug release patterns were comparable to industry standards. This formulation showed promise as an alternative method for delivering steroidal molecules transdermally.
